IBB look out belowIt was a good run, but what goes up must come down, and IBB has a long way to fall. I would short it
Key stats
About iShares Biotechnology ETF
Home page
Inception date
Feb 5, 2001
Structure
Open-Ended Fund
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
BlackRock Fund Advisors
Distributor
BlackRock Investments LLC
IBB tracks an index of US biotechnology companies listed on the major US exchanges. This includes companies engaged in the research and development of therapeutic treatments but are not focused on the commercialization and mass production of pharmaceutical drugs. This also includes companies that are engaged in the production of tools or systems that enable biotechnology processes. IBB includes companies of all capitalizations, and weights using a modified market-cap methodology. Individual holdings are subject to capping requirements, 8% on the five largest constituents and 4% for the remaining. The index is rebalanced quarterly and fully reconstituted annually in December. Prior to June 21, 2021, the fund was named iShares Nasdaq Biotechnology ETF and tracked the NASDAQ Biotechnology Index.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Has the Market Been Shitting On You?It's no secret that markets are tough to navigate right now. That is why I have been finding sectors with potential and direction. While this one only has one of those characteristics, it is waiting for volatility expansion, and all signs point to the downside.
We don't need to trade everyday but,
ABCD Move in IBBWith the tech decay started already, the next will be bio-tech. In the long term it pays to be long biotech, but in the short term there is a valuable trade to be made here.
Biotech for continuationBiotech ETF has held up well, and looks primed for bullish continuation. My guess is biotech brands are ramping up. They patent the altered viruses, and then sell you vaccines in a Faustian and Hegelian mix up.
Biotech for continuationBiotech ETF has held up well, and looks primed for bullish continuation. My guess is biotech brands are ramping up. They patent the altered viruses, and then sell you vaccines in a Faustian and Hegelian mix up.
IBB Biotech is due for a runAt some point there will be a boom biotechnology stocks. They haven't done much in the past ten years. I believe IBB will pass 250 within the decade. However, if the market remains stable, without any 20%+ corrections, I think IBB hits 250 to 300 in the next year
IBB - iShares Biotech EFT - SHORT (Wyckoff Redistribution)IBB looks to be in a Wyckoff Redistribution phase, with UTAD emerging currently.
On a larger time frame, looks as though a weekly H&S patter forming with the re-distribution section acting as the right shoulder.
My price target is $57, in line with the 1.618 fib extension.
IBB - long way to go.I will not be bullish in Biotech until we reach the lows (-39% correction) or until we reach new highs.
Should be a lot of mess here, for long period of time without a trend.
IBB d2 accumulation buy/hold setup 40% gains🔸Hello guys, today let's review 2daily chart for IBB . Entering re-accumulation
stage now, expecting range bound trading during autumn time season.
Range defined by range highs set at 135 usd and range lows at 117 usd.
🔸Similar fractal observed in 2018/2019. Faded into range after heavy spike,
re-
IBB Entry, Volume, Target, Stop, ResistanceEntry: with price above 133.81
Volume: with volume greater than 1.67M
Target: 138.50 area
Stop: Depending on your risk tolerance; Based on an entry of 133.82, 132.25 gets you 3/1 Reward to Risk Ratio.
Resistance: 135 area
This swing trade idea is not trade advice and is strictly based on my ideas a
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.